FN2 Earnings Intelligence
Medpace Holdings, Inc. ratios (quarterly)
Medpace Holdings, Inc. (MEDP) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 3/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $46.3 | $285.4 | $652.7 | $502.7 | $705.3 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $603.3 | $659.9 | $706.6 | $707.3 | $716 | $720.9 | $728.6 |
| % Growth | - | - | - | - | - | - | 3.1% |
| Gross Profit | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| EBITDA | $133.1 | $148.6 | $148.3 | $153.4 | $172 | - | - |
| % Margin | 22.1% | 22.5% | 21.0% | 21.7% | 24.0% | - | - |
| Net Income | $90.3 | $111.1 | $123.9 | $121.4 | $137.5 | - | - |
| % Margin | 15.0% | 16.8% | 17.5% | 17.2% | 19.2% | - | - |
| Diluted EPS | $3.10 | $3.86 | $4.28 | $4.25 | $4.84 | $4.65 | $4.62 |
| % Growth | - | - | - | - | - | - | 7.9% |
| Operating Cash Flow | - | - | $151.8 | - | - | - | - |
| CapEx | - | - | $6.8 | - | - | - | - |
| Free Cash Flow | - | - | $145 | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 3/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $603.3 | $659.9 | $706.6 | $707.3 | $716 | $720.9 | $728.6 |
| Gross Profit | - | - | - | - | - | - | - |
| EBITDA | $133.1 | $148.6 | $148.3 | $153.4 | $172 | - | - |
| Net Income | $90.3 | $111.1 | $123.9 | $121.4 | $137.5 | - | - |
| Diluted EPS | $3.10 | $3.86 | $4.28 | $4.25 | $4.84 | $4.65 | $4.62 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $46.3 | $285.4 | $652.7 | $502.7 | $705.3 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $151.8 | - | - |
| Capital Expenditure | - | - | $6.8 | - | - |
| Free Cash Flow | - | - | $145 | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | 22.1% | 22.5% | 21.0% | 21.7% | 24.0% |
| Net Margin | 15.0% | 16.8% | 17.5% | 17.2% | 19.2% |
| FCF Margin | - | - | 20.5% | - | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the MEDP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.